Regeneron Antibody Treatment in Focus After President's Praises, Pharma Company Seeks Emergency Use Authorization From FDA

After President Trump touted it as a quote "cure" for coronavirus, Regeneron is seeking emergency use authorization for its antibody treatment. This treatment is still in testing and has not been approved for widespread use. The drugmaker says it has seen an uptick in interest from people wanting to participate in the trial. For more on the latest coronavirus antibody treatments, we spoke to Doctor Jennifer Bath, expert in antibody based therapeutics and the CEO of ImmunoPrecise, a company that specializes in finding and creating antibody treatments.
We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.